Vienna, Austria: – Recombinant protein specialist enGenes Biotech GmbH (enGenes) will be a new presence at the upcoming European Forum for Industrial Biotechnology & the Bioeconomy (EFIB 2019) in Brussels.
enGenes will use its first appearance at the annual partnering event to present successful applications of its proprietary enGenes-eXpress technology in boosting recombinant protein and DNA yields to the Industrial Biotech sector.
Industrial biotech contribution
“This is an excellent opportunity to share latest news on our exciting enGenes-eXpress platform. It has shown big potential to increase yields of recombinant proteins, even of difficult to express ones. We will reach out to new clients, establish new business relationships and share knowledge with leading figures in the industrial biotech arena,” commented enGenes CEO and CSO, Dr. Juergen Mairhofer.
For more information follow https://www.pharmaceutical-networking.com/engenes-brings-enhanced-protein-yield-opportunities-to-efib-brussels/
Kommentare